Showing results (311-320 of 320) with videos related to
Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 320 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 16, 2024
Clinical Activity of TGF-β Inhibitor Vactosertib in Combination with Imatinib in Desmoid Tumors: A Multicenter Phase Ib/II StudyJin-Hee Ahn, Jeeyun Lee, Changhee Park, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2026
Phase IB/II Trial with Correlative Analyses of Doxorubicin plus Durvalumab Combination in Patients with Advanced Soft Tissue SarcomaKum-Hee Yun, Nam Suk Sim, Su-Jin Shin, et al.Nature Communications|January 23, 2024
Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trialHee Jin Cho, Kum-Hee Yun, Su-Jin Shin, et al.The Journal of Biological Chemistry|February 1, 2002
alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cellsBong-Hyun Ahn, Hyangshuk Rhim, Shi Yeon Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2022
Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or LeiomyosarcomaChang Gon Kim, Nam Suk Sim, Jeong Eun Kim, et al.BMC Cancer|February 9, 2018
Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcomaYong Jin Cho, Soo Hee Kim, Eun Kyung Kim, et al.BMC Cancer|July 10, 2016
Prognostic implications of PD-L1 expression in patients with soft tissue sarcomaChan Kim, Eun Kyung Kim, Hun Jung, et al.Oncology|October 19, 2018
Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue SarcomaJee Hung Kim, Hyung Soon Park, Su Jin Heo, et al.Journal of Cancer|June 22, 2016
Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional ExperienceYoon Jung Oh, Seong Yoon Yi, Ki Hyang Kim, et al.Oncotarget|March 27, 2016
Prognostic implications of PIK3CA amplification in curatively resected liposarcomaJoo Hoon Kim, Jae Seok Lee, Eo Jin Kim, et al.Pageof 32